High-Sensitivity Troponin Implementation

General Information 

Munson Healthcare transitioned to a new cardiac troponin assay — High-Sensitivity Troponin (hs-TnI) assay — in April 2022.

Most patients presenting to an Emergency Department with a chief complaint of chest pain are not actually having an acute coronary syndrome event. The hs-TnI lab assay allows faster, more accurate information about cardiac injury, facilitating quicker intervention for those who are high risk and actually experiencing a cardiac event and quicker rule-out and discharge for low risk patients.

Click here for more information about why this implementation will be great for our patients.

Click here to download a PPT that can be shared with your colleagues

Treatment Algorithm

Scan the QR code below for the hs-Tnl Treatment Algorithm 

Educational Resources 

On-Demand CME 

• Recorded Lecture: Transition to High Sensitivity Troponin Testing Across the MHC System: What you need to know: Click here
• Self-directed CME Activity: High Sensitivity Troponin: Overview and Case Studies: Click here

Reference Information

• JACC Article: Latest in ED Risk Stratification of Chest Pain: hs-cTn and Risk Scores
• Circulation Article: High-Sensitivity Cardiac Troponin: A Stepped-Wedge Cluster RCT
• Circulation Article: Prognostic Utility of a Modified HEART Score in Chest Pain Patients in the ED
• Calculating the HEART Score